You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Availability of essential medicines by healthcare facility levels in a selected high-performing division (Rajshahi) and a low-performing division (Sylhet) in Bangladesh

From: General service and child immunization-specific readiness assessment of healthcare facilities in two selected divisions in Bangladesh

Variable Rajshahi (N = 61) Sylhet (N = 62)
  Pharmacy Community clinic Primary care facilities Higher care facilities Pharmacy Community clinic Primary care facilities Higher care facilities
Albendazole [n (%)] 10 (83.3) 12 (100.0) 12 (80.0) 3 (13.6) 9 (75.0) 13 (100.0) 14 (93.3) 10 (45.5)
Amoxicillin Cap [n (%)] 11 (91.7) 11 (91.7) 6 (40.0) 4 (18.2) 10 (83.3) 12 (92.3) 6 (40.0) 11 (50.0)
Amoxicillin Syrup/Pediatric suspension [n (%)] 11 (91.7) 12 (100.0) 7 (46.7) 2 (9.1) 8 (66.7) 12 (92.3) 10 (66.7) 7 (31.8)
Antacid [n (%)] 11 (91.7) 12 (100.0) 11 (73.3) 5 (22.7) 10 (83.3) 13 (100.0) 15 (100.0) 10 (45.5)
Benzoic Acid and Salicylic Acid Ointment [n (%)] 6 (50.0) 12 (100.0) 6 (40.0) 4 (18.2) 3 (25.0) 12 (92.3) 3 (20.0) 3 (13.6)
Benzyl Benzoate Lotion Application [n(%)] 1 (8.3) 12 (100.0) 4 (26.7) 1 (4.5) 3 (25.0) 11 (84.6) 4 (26.7) 3 (13.6)
Calcium Lactated Tab [n (%)] 9 (75.0) 12 (100.0) 3 (20.0) 4 (18.2) 9 (75.0) 12 (92.3) 5 (33.3) 10 (45.5)
Chloramphenicol Eye/Ear/Ointment/Drops [n (%)] 8 (66.7) 12 (100.0) 8 (53.3) 4 (18.2) 11 (91.7) 12 (92.3) 10 (66.7) 9 (40.9)
Chlorpheniramine Maleate Tablet [n (%)] 4 (33.3) 12 (100.0) 8 (53.3) 4 (18.2) 6 (50.0) 10 (76.9) 5 (33.3) 6 (27.3)
Cotriomoxazole Tab [n (%)] 7 (58.3) 12 (100.0) 10 (66.7) 2 (9.1) 6 (50.0) 10 (76.9) 14 (93.3) 5 (22.7)
Doxycycline [n (%)] 12 (100.0) 12 (100.0) 7 (46.7) 3 (13.6) 10 (83.3) 12 (92.3) 11 (73.3) 10 (45.5)
Ferrous Sulphate Tablet/ Syrup [n (%)] 6 (50.0) 0 (0.0) 4 (26.7) 4 (18.2) 7 (58.3) 0 (0.0) 8 (53.3) 7 (31.8)
Folic Acid Tablet [n (%)] 11 (91.7) 9 (75.0) 11 (73.3) 2 (9.1) 9 (75.0) 11 (84.6) 10 (66.7) 9 (40.9)
Gentian Violet Topical Solution [n (%)] 1 (8.3) 12 (100.0) 0 (0.0) 1 (4.5) 4 (33.3) 11 (84.6) 0 (0.0) 2 (9.1)
Hyoscine ButyIbromide [n (%)] 8 (66.7) 12 (100.0) 4 (26.7) 3 (13.6) 2 (16.7) 13 (100.0) 2 (13.3) 9 (40.9)
Mebendazole Tablet [n (%)] 6 (50.0) 0 (0.0) 0 (0.0) 5 (22.7) 8 (66.7) 0 (0.0) 4 (26.7) 14 (63.6)
Neomycin Bacitracin skin ointment [n (%)] 7 (58.3) 12 (100.0) 4 (26.7) 2 (9.1) 8 (66.7) 12 (92.3) 3 (20.0) 6 (27.3)
ORS (Oral Rehydration Salt) [n (%)] 12 (100.0) 12 (100.0) 7 (46.7) 5 (22.7) 10 (83.3) 13 (100.0) 10 (66.7) 12 (54.5)
Paracetamol suspension/syrup [n (%)] 12 (100.0) 12 (100.0) 9 (60.0) 4 (18.2) 8 (66.7) 11 (84.6) 7 (46.7) 10 (45.5)
Paracetamol Tab Tablet/Elixir [n (%)] 11 (91.7) 12 (100.0) 11 (73.3) 5 (22.7) 10 (83.3) 12 (92.3) 15 (100.0) 14 (63.6)
Benzathine Penicillin [n (%)] 2 (16.7) 0 (0.0) 1 (6.7) 1 (4.5) 3 (25.0) 0 (0.0) 1 (6.7) 4 (18.2)
Salbutamol syrup [n (%)] 10 (83.3) 12 (100.0) 2 (13.3) 4 (18.2) 5 (41.7) 11 (84.6) 2 (13.3) 8 (36.4)
Salbutamol Tablet/Elixir/Inhaler/Injection [n (%)] 10 (83.3) 12 (100.0) 7 (46.7) 5 (22.7) 7 (58.3) 11 (84.6) 12 (80.0) 12 (54.5)
Vitamin A Cap (200,000 I.U.) [n (%)] 9 (75.0) 12 (100.0) 3 (20.0) 1 (4.5) 7 (58.3) 13 (100.0) 5 (33.3) 4 (18.2)
Vitamin B- Complex Tablet/Multi-vitamin D drops 15 ml [n (%)] 12 (100.0) 12 (100.0) 11 (73.3) 4 (18.2) 10 (83.3) 13 (100.0) 14 (93.3) 12 (54.5)
Zinc [n (%)] 11 (91.7) 12 (100.0) 3 (20.0) 4 (18.2) 10 (83.3) 11 (84.6) 6 (40.0) 10 (45.5)
Domain score (Mean availability of items as percentage) [Mean (SE)] 69.9 (5.6) 87.2 (6.4) 40.8 (4.7) 15.0 (1.2) 61.9 (4.4) 80.2 (5.9) 50.3 (6.1) 37.9 (3.0)
  1. N Total number of facilities, n Number of facilities in specific category, SE Standard error